Treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimus
Putao Cen, Robert J AmatoDivision of Oncology, Department of Internal Medicine, University of Texas Health Science Center at Houston (Medical School), Houston, TXAbstract: Pancreatic neuroendocrine tumors (PanNETs) are frequently diagnosed at unresectable stage and remain a medical challenge. Everol...
Main Authors: | Cen P, Amato RJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-04-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/treatment-of-advanced-pancreatic-neuroendocrine-tumors-potential-role--a9622 |
Similar Items
-
Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
by: Yim K-L
Published: (2012-07-01) -
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential
by: Sara Pusceddu, et al.
Published: (2017-03-01) -
Emerging use of everolimus in the treatment of neuroendocrine tumors
by: Gajate P, et al.
Published: (2017-06-01) -
Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment
by: Eleonora Vitali, et al.
Published: (2020-08-01) -
mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus
by: Fabio Gelsomino, et al.
Published: (2020-05-01)